Skinvisible (SKVI) Cash & Equivalents (2016 - 2025)
Skinvisible (SKVI) has disclosed Cash & Equivalents for 15 consecutive years, with $2620.0 as the latest value for Q4 2025.
- Quarterly Cash & Equivalents fell 74.65% to $2620.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2620.0 through Dec 2025, down 74.65% year-over-year, with the annual reading at $2620.0 for FY2025, 74.65% down from the prior year.
- Cash & Equivalents hit $2620.0 in Q4 2025 for Skinvisible, up from $645.0 in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $160336.0 in Q2 2022 to a low of $120.0 in Q2 2025.
- Historically, Cash & Equivalents has averaged $32712.4 across 5 years, with a median of $11501.5 in 2021.
- Biggest five-year swings in Cash & Equivalents: plummeted 99.43% in 2023 and later surged 1063.96% in 2024.
- Year by year, Cash & Equivalents stood at $66037.0 in 2021, then grew by 23.23% to $81378.0 in 2022, then tumbled by 98.91% to $888.0 in 2023, then soared by 1063.96% to $10336.0 in 2024, then crashed by 74.65% to $2620.0 in 2025.
- Business Quant data shows Cash & Equivalents for SKVI at $2620.0 in Q4 2025, $645.0 in Q3 2025, and $120.0 in Q2 2025.